Abstract

Radiotherapy (RT) is very much a technology-driven treatment modality in the management of cancer. RT techniques have changed significantly over the past few decades, thanks to improvements in engineering and computing. We aim to highlight the recent developments in radiation oncology, focusing on the technological and biological advances. We will present state-of-the-art treatment techniques, employing photon beams, such as intensity-modulated RT, volumetric-modulated arc therapy, stereotactic body RT and adaptive RT, which make possible a highly tailored dose distribution with maximum normal tissue sparing. We will analyse all the steps involved in the treatment: imaging, delineation of the tumour and organs at risk, treatment planning and finally image-guidance for accurate tumour localisation before and during treatment delivery. Particular attention will be given to the crucial role that imaging plays throughout the entire process. In the case of adaptive RT, the precise identification of target volumes as well as the monitoring of tumour response/modification during the course of treatment is mainly based on multimodality imaging that integrates morphological, functional and metabolic information. Moreover, real-time imaging of the tumour is essential in breathing adaptive techniques to compensate for tumour motion due to respiration.Brief reference will be made to the recent spread of particle beam therapy, in particular to the use of protons, but also to the yet limited experience of using heavy particles such as carbon ions.Finally, we will analyse the latest biological advances in tumour targeting. Indeed, the effectiveness of RT has been improved not only by technological developments but also through the integration of radiobiological knowledge to produce more efficient and personalised treatment strategies.

Highlights

  • Radiotherapy (RT) plays a crucial role in the care of cancer with approximately 50% of all patients benefiting from RT in the management of their disease [1,2,3]

  • RT can be offered as the sole radical treatment

  • RT has an effect on the dissemination of the tumour in that local/regional therapies are, in effect, ‘stopping metastases at their source’ [10]

Read more

Summary

Introduction

RT can be offered as the sole radical treatment It can be combined with surgery, being given during (intraoperative), before (neoadjuvant) or after resection (adjuvant), or with systemic therapy, sometimes for organ preservation (such as larynx, breast, urinary bladder, etc) [4,5,6]. It can provide symptom relief in cancers that are locally advanced or disseminated by reducing or eliminating pain from bone metastases in 60% of cases [7,8,9]. The possibility of the abscopal effect has been raised on the basis of a remission in out-target lesions after localised RT [11]

Objectives
Findings
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.